Skip to main content
Fig. 6 | Clinical Proteomics

Fig. 6

From: Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay

Fig. 6

Workflow of method development and validation to quantify target proteins using PRM assay in HGSOC. A Schematic of the experimental design. This study is divided into (1) Target peptide selection, (2) Method development and validation, and (3) Endogenous target quantification to identify candidate diagnostic biomarkers in HGSOC. B Assay validation acceptability criteria. The flowchart shows the number of peptides passing acceptability criteria

Back to article page

Clinical Proteomics

ISSN: 1559-0275